ReviewOne health (Amsterdam, Netherlands)2021
Review in One health (Amsterdam, Netherlands), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.
- Vectors, host range, and spatial distribution of Dirofilaria immitis and D. repens in Europe: a systematic review.Infectious diseases of poverty · 2025Pooled it
- Molecular detection and characterization of filarioid nematodes in wild armadillos and anteaters from Central-Western Brazil.Veterinary research communications · 2026Article
- Article
- Genital Dirofilaria: A Comprehensive Review of Clinical Presentations, Diagnosis and Management.Acta parasitologica · 2026Review
- Dirofilariasis presenting with recurrent solitary erythematous swellings and creeping dermatitis.Journal of travel medicine · 2025Article
- Global prevalence, diagnostics and epidemiological trends of canine filariosis and associated zoonotic infections (2021-2025): a review.Veterinary research communications · 2025Review
- Circulation ofLife (Basel, Switzerland) · 2025Article
- Not a Dead-End Host: First Confirmed Persistent Microfilaremia in HumanMicroorganisms · 2025Article
- Article
- Article
- Vector-borne pathogens in dogs from the Republic of Kosovo.Parasites & vectors · 2025Article
- Uncovering humanParasitology · 2025Article
- Integrative taxonomy in helminth analysis: protocols and limitations in the twenty-first century.Parasites & vectors · 2025Review
- A Rare Case Report of a HumanMicroorganisms · 2025Article
- Case report: Dirofilarial infection of the face.IDCases · 2025Article
- Rare case of extralymphatic dirofilariasis presenting as a facial subcutaneous nodule in non-endemic region of Spain.IDCases · 2025Article
- Lesion on the right testicle of 21-year-old patient.One health (Amsterdam, Netherlands) · 2024Article
- Dirofilariasis of the scrotum: a clinical case from Bulgaria.Helminthologia · 2024Article
- Detection of Dirofilaria immitis in golden jackals (Canis aureus L.) but not in red foxes (Vulpes vulpes L.) and European badgers (Meles meles L.) in Croatia.Parasites & vectors · 2024Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introduction
methodsIn the current study, we present the detection of multiple adults of
resultsWithin the study population, there were 13 (59.09%) males, eight (36.36%) females and, in one (4.55%) case, sex was not reported. A total of 11 (50.00%) cases had subcutaneous dirofilariasis, six (27.27%) had ocular dirofiliariasis, with single cases (4.55% each) of genital, mammary, lymphatic and a combination of subcutaneous and pulmonary dirofilariasis described. In one (4.55%) case, the primary anatomical site of adult
conclusionThe results of this study suggest that humans may act as a final host for
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.